Connection

GIULIO DRAETTA to Mutation

This is a "connection" page, showing publications GIULIO DRAETTA has written about Mutation.
Connection Strength

0.425
  1. The KRAS mutational spectrum and its clinical implications in pancreatic cancer. Cancer Cell. 2024 Sep 09; 42(9):1494-1496.
    View in: PubMed
    Score: 0.233
  2. Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer. Gastroenterology. 2021 07; 161(1):196-210.
    View in: PubMed
    Score: 0.046
  3. Tumors and mitochondrial respiration: a neglected connection. Cancer Res. 2015 Sep 15; 75(18):3685-6.
    View in: PubMed
    Score: 0.031
  4. Mutations at sites involved in Suc1 binding inactivate Cdc2. Mol Cell Biol. 1991 Dec; 11(12):6177-84.
    View in: PubMed
    Score: 0.024
  5. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med. 2007 Aug 06; 204(8):1813-24.
    View in: PubMed
    Score: 0.018
  6. Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis. Science. 2021 Sep 17; 373(6561):eabj0486.
    View in: PubMed
    Score: 0.012
  7. Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward Osimertinib. Cancer Res. 2020 11 01; 80(21):4840-4853.
    View in: PubMed
    Score: 0.011
  8. Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal Adenocarcinoma. Cancer Res. 2019 Nov 01; 79(21):5612-5625.
    View in: PubMed
    Score: 0.010
  9. Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma. Sci Transl Med. 2019 05 08; 11(491).
    View in: PubMed
    Score: 0.010
  10. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature. 2014 Oct 30; 514(7524):628-32.
    View in: PubMed
    Score: 0.007
  11. Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src. EMBO J. 1993 Jul; 12(7):2625-34.
    View in: PubMed
    Score: 0.007
  12. Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis. Am J Pathol. 2010 Jul; 177(1):415-23.
    View in: PubMed
    Score: 0.005
  13. Transforming growth factor beta facilitates beta-TrCP-mediated degradation of Cdc25A in a Smad3-dependent manner. Mol Cell Biol. 2005 Apr; 25(8):3338-47.
    View in: PubMed
    Score: 0.004
  14. p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J. 2001 Dec 03; 20(23):6672-82.
    View in: PubMed
    Score: 0.003
  15. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Am J Pathol. 1998 Sep; 153(3):681-7.
    View in: PubMed
    Score: 0.002
  16. Genetically engineered calmodulins differentially activate target enzymes. J Biol Chem. 1986 Jul 25; 261(21):9896-903.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.